| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACO1
|
aconitase 1, soluble
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAP1
|
ArfGAP with dual PH domains 1
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADD2
|
adducin 2 (beta)
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFAP1
|
actin filament associated protein 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
APLP1
|
amyloid beta (A4) precursor-like protein 1
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta
|
|
ATF2
|
activating transcription factor 2
|
|
ATP5C1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BEST1
|
bestrophin 1
|
|
BLVRA
|
biliverdin reductase A
|
|
BNC1
|
basonuclin 1
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CASR
|
calcium-sensing receptor
|
|
CD226
|
CD226 molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD4
|
CD4 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD5
|
CD5 molecule
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAT
|
choline O-acetyltransferase
|
|
CLDN4
|
claudin 4
|
|
CLDN7
|
claudin 7
|
|
CORO1B
|
coronin, actin binding protein, 1B
|
|
CREBBP
|
CREB binding protein
|
|
CREM
|
cAMP responsive element modulator
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTPS1
|
CTP synthase 1
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYTH2
|
cytohesin 2
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DLG1
|
discs, large homolog 1 (Drosophila)
|
|
DLX3
|
distal-less homeobox 3
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNM1
|
dynamin 1
|
|
DTNB
|
dystrobrevin, beta
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN2
|
egl-9 family hypoxia-inducible factor 2
|
|
EIF2S3
|
eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EIF6
|
eukaryotic translation initiation factor 6
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ENAH
|
enabled homolog (Drosophila)
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EZR
|
ezrin
|
|
F11R
|
F11 receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas 1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GLRB
|
glycine receptor, beta
|
|
GMFB
|
glia maturation factor, beta
|
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
|
GPSM2
|
G-protein signaling modulator 2
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRIA2
|
glutamate receptor, ionotropic, AMPA 2
|
|
GRID2
|
glutamate receptor, ionotropic, delta 2
|
|
GRIK2
|
glutamate receptor, ionotropic, kainate 2
|
|
GRK7
|
G protein-coupled receptor kinase 7
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HABP4
|
hyaluronan binding protein 4
|
|
HEXIM1
|
hexamethylene bis-acetamide inducible 1
|
|
HIST1H2BB
|
histone cluster 1, H2bb
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HOXA9
|
homeobox A9
|
|
HRH1
|
histamine receptor H1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
ILK
|
integrin-linked kinase
|
|
INSR
|
insulin receptor
|
|
IQGAP1
|
IQ motif containing GTPase activating protein 1
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB4
|
integrin, beta 4
|
|
JPH2
|
junctophilin 2
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNAB2
|
potassium channel, voltage gated subfamily A regulatory beta subunit 2
|
|
KCNC4
|
potassium channel, voltage gated Shaw related subfamily C, member 4
|
|
KCNE3
|
potassium channel, voltage gated subfamily E regulatory beta subunit 3
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ1
|
potassium channel, inwardly rectifying subfamily J, member 1
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNJ13
|
potassium channel, inwardly rectifying subfamily J, member 13
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRT20
|
keratin 20, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LMNA
|
lamin A/C
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKLN1
|
muskelin 1, intracellular mediator containing kelch motifs
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MYBPC1
|
myosin binding protein C, slow type
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MYL9
|
myosin, light chain 9, regulatory
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NLGN4X
|
neuroligin 4, X-linked
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX5
|
NADPH oxidase, EF-hand calcium binding domain 5
|
|
NOXA1
|
NADPH oxidase activator 1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR2C1
|
nuclear receptor subfamily 2, group C, member 1
|
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6
|
|
OCLN
|
occludin
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PA2G4
|
proliferation-associated 2G4, 38kDa
|
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta
|
|
PITPNB
|
phosphatidylinositol transfer protein, beta
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB3
|
phospholipase C, beta 3 (phosphatidylinositol-specific)
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PLEK
|
pleckstrin
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A
|
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKD3
|
protein kinase D3
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALBP1
|
ralA binding protein 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RET
|
ret proto-oncogene
|
|
RGS7
|
regulator of G-protein signaling 7
|
|
RHO
|
rhodopsin
|
|
ROBO3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila)
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RSC1A1
|
regulatory solute carrier protein, family 1, member 1
|
|
SH2B1
|
SH2B adaptor protein 1
|
|
SIK1
|
salt-inducible kinase 1
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SPN
|
sialophorin
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAGLN
|
transgelin
|
|
TAGLN2
|
transgelin 2
|
|
TBXA2R
|
thromboxane A2 receptor
|
|
TDG
|
thymine-DNA glycosylase
|
|
TFRC
|
transferrin receptor
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
THOC5
|
THO complex 5
|
|
TMPO
|
thymopoietin
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TRPV5
|
transient receptor potential cation channel, subfamily V, member 5
|
|
TRPV6
|
transient receptor potential cation channel, subfamily V, member 6
|
|
TTN
|
titin
|
|
TUBA1C
|
tubulin, alpha 1c
|
|
TXN
|
thioredoxin
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VIM
|
vimentin
|
|
VTN
|
vitronectin
|
